180 related articles for article (PubMed ID: 9328365)
1. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.
Yang WS; Min WK; Park JS; Kim SB
Am J Kidney Dis; 1997 Oct; 30(4):507-13. PubMed ID: 9328365
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
Kim SB; Yang WS; Kang ES; Min WK; Park JS
Perit Dial Int; 1997; 17(3):236-42. PubMed ID: 9237283
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
[TBL] [Abstract][Full Text] [Related]
6. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
Bartens W; Nauck M; Schollmeyer P; Wanner C
Perit Dial Int; 1996; 16(1):27-33. PubMed ID: 8616169
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
[TBL] [Abstract][Full Text] [Related]
10. Effect of increasing serum albumin on haemostatic factors synthesized in the liver in CAPD patients.
Kim SB; Yang WS; Lee SK; Chi HS; Park JS
Nephrol Dial Transplant; 1998 Aug; 13(8):2053-8. PubMed ID: 9719164
[TBL] [Abstract][Full Text] [Related]
11. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
12. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
Tanaka S
Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
[TBL] [Abstract][Full Text] [Related]
13. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.
Stenvinkel P; Heimbürger O; Tuck CH; Berglund L
Kidney Int; 1998 May; 53(5):1336-42. PubMed ID: 9573549
[TBL] [Abstract][Full Text] [Related]
14. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
Kandoussi A; Cachera C; Pagniez D; Dracon M; Fruchart JC; Tacquet A
Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) and treatment of chronic renal disease.
Buggy D; Breathnach A; Keogh B; Cooke T; Feely J
J Intern Med; 1993 Nov; 234(5):453-5. PubMed ID: 8228788
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J
Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
[TBL] [Abstract][Full Text] [Related]
17. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.
Topciu Shufta V; Begolli L; Kryeziu E
Bosn J Basic Med Sci; 2010 Feb; 10(1):19-25. PubMed ID: 20192926
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
[TBL] [Abstract][Full Text] [Related]
20. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
